Prolonged stability of 1% 5-FU eye drops as topical chemotherapy for ocular surface squamous neoplasia

Michael Antonietti, Despoina Theotoka, Mak B. Djulbegovic, Gregory S. Gorman, Matthew Massey, Anat Galor, Carol L. Karp

Open source

DOI
10.1016/j.jtos.2026.02.002
Published
2026-04
Container
The Ocular Surface
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtos.2026.02.002,
  title = {Prolonged stability of 1\% 5-FU eye drops as topical chemotherapy for ocular surface squamous neoplasia},
  author = {Michael Antonietti and Despoina Theotoka and Mak B. Djulbegovic and Gregory S. Gorman and Matthew Massey and Anat Galor and Carol L. Karp},
  year = {2026},
  journal = {The Ocular Surface},
  doi = {10.1016/j.jtos.2026.02.002},
  url = {https://doi.org/10.1016/j.jtos.2026.02.002}
}

RIS

TY  - JOUR
TI  - Prolonged stability of 1% 5-FU eye drops as topical chemotherapy for ocular surface squamous neoplasia
AU  - Michael Antonietti
AU  - Despoina Theotoka
AU  - Mak B. Djulbegovic
AU  - Gregory S. Gorman
AU  - Matthew Massey
AU  - Anat Galor
AU  - Carol L. Karp
PY  - 2026
JO  - The Ocular Surface
DO  - 10.1016/j.jtos.2026.02.002
UR  - https://doi.org/10.1016/j.jtos.2026.02.002
ER  - 

APA

Antonietti, M., Theotoka, D., Djulbegovic, M. B., Gorman, G. S., Massey, M., Galor, A., & Karp, C. L. (2026). Prolonged stability of 1% 5-FU eye drops as topical chemotherapy for ocular surface squamous neoplasia. The Ocular Surface. https://doi.org/10.1016/j.jtos.2026.02.002

Source records